Assessment
Questionnaire

Have a symptom?
See what questions
a doctor would ask.
 
Diseases » Lung cancer » Deaths
 

Deaths from Lung cancer

Lung cancer: Deaths

Deaths from Lung cancer: 160,440 estimated deaths for lung/bronchial cancer in the US 2004 (Cancer Facts and Figures, American Cancer Society, 2004)

Death Rate Extrapolation

Death rate extrapolations for USA for Lung cancer: 160,439 per year, 13,369 per month, 3,085 per week, 439 per day, 18 per hour, 0 per minute, 0 per second. Note: this automatic extrapolation calculation uses the deaths statistic: 160,440 estimated deaths for lung/bronchial cancer in the US 2004 (Cancer Facts and Figures, American Cancer Society, 2004)

Survival rate statistics for Lung cancer

The following are statistics from various sources about the survival rate for Lung cancer:

  • 15% of white people survive 5 years for lung/bronchial cancer in the US 1992-99 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 12% of African American people survive 5 years for lung/bronchial cancer in the US 1992-99 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 15% survive 5 years for lung/bronchial cancer in the US 1992-99 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 13.4% of people with lung and bronchial cancer survive after 5 years in the US 1983-90 (SEER)
  • 5-year survival rate for black people with lung and bronchus cancer is 11.1% in the US 1983-90 (SEER)
  • 5-year survival rate for people with lung and bronchus cancer is 13.4% in the US 1983-90 (SEER)
  • 5-year survival rate for white people with lung and bronchus cancer is 13.7% in the US 1983-90 (SEER)
  • 1-year survival rate for men aged 15-99 with lung cancer is 21% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for men aged 15-99 with lung cancer is 5.2% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for men aged 15-39 with lung cancer is 35% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for men aged 15-39 with lung cancer is 16% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for men aged 40-49 with lung cancer is 29% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for men aged 40-49 with lung cancer is 10% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for men aged 50-59 with lung cancer is 27% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for men aged 50-59 with lung cancer is 8% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for men aged 60-69 with lung cancer is 24% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for men aged 60-69 with lung cancer is 6% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for men aged 70-79 with lung cancer is 19% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for men aged 70-79 with lung cancer is 4% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for men aged 80-99 with lung cancer is 12% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for men aged 80-99 with lung cancer is 1% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 15-99 with lung cancer is 21.3% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 15-99 with lung cancer is 5.4% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 15-39 with lung cancer is 45% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 15-39 with lung cancer is 27% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 40-49 with lung cancer is 32% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 40-49 with lung cancer is 10% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 50-59 with lung cancer is 29% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 50-59 with lung cancer is 9% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 60-69 with lung cancer is 24% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 60-69 with lung cancer is 6% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 70-79 with lung cancer is 19% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 70-79 with lung cancer is 4% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 80-99 with lung cancer is 12% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 80-99 with lung cancer is 2% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 4 months is the median survival for patients with advanced lung cancer at time of diagnosis (Cancer, Vol 2, No. 8: 2211-2219, American Cancer Society)
  • 13 months is the median survival for patients with advanced lung cancer who are still alive two years after diagnosis (Cancer, Vol 2, No. 8: 2211-2219, American Cancer Society)
  • Over 4 years is the median survival for patients with advanced lung cancer who are still alive five years after diagnosis (Cancer, Vol 2, No. 8: 2211-2219, American Cancer Society)

Misdiagnosis and Lung cancer deaths

Lung cancer can be deadly if misdiagnosed...more »

Death statistics for Lung cancer

The following are statistics from various sources about deaths and Lung cancer:

  • 152,000 deaths in 1999 (CDC); 28% of cancer deaths; 152,182 deaths reported in USA 1999 (NVSR Sep 2001)
  • 91,930 estimated male deaths for lung/bronchial cancer in the US 2004 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 68,510 estimated female deaths for lung/bronchial cancer in the US 2004 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 2,543 women died from lung cancer in Australia 2002 (AIHW National Morbidity Database, Australia’s Health 2004, AIHW)
  • 3.9% of all female deaths was due to lung cancer in Australia 2002 (AIHW National Morbidity Database, Australia’s Health 2004, AIHW)
  • 4,760 men died from lung cancer in Australia 2002 (AIHW National Morbidity Database, Australia’s Health 2004, AIHW)
  • 6.9% of all male deaths was due to lung cancer in Australia 2002 (AIHW National Morbidity Database, Australia’s Health 2004, AIHW)
  • Lung and bronchial cancer death statistics in various racial groups in the USA:
    • 78.1 white men per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
    • 107 African American men per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
    • 40.9 Asian American and Pacific Islander men per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
    • 52.9 American Indian and Alaska Native men per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
    • 40.7 Hispanic Latino men per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
    • 41.5 white women per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
    • 40 African American women per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
    • 19.1 Asian American and Pacific Islander women per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
    • 26.2 American Indian and Alaska Native women per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
    • 15.1 Hispanic Latino women per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
  • 10,700 deaths in men from lung cancer in Canada 2004 (Canadian Cancer Statistics, National Cancer Institute of Canada, 2004)
  • 8,200 deaths in women from lung cancer in Canada 2004 (Canadian Cancer Statistics, National Cancer Institute of Canada, 2004)
  • 66 per 100,000 deaths in men from lung cancer in Canada 2004 (Canadian Cancer Statistics, National Cancer Institute of Canada, 2004)
  • 40 per 100,000 deaths in women from lung cancer in Canada 2004 (Canadian Cancer Statistics, National Cancer Institute of Canada, 2004)
  • 11,900 new cases in men from lung cancer in Canada 2004 (Canadian Cancer Statistics, National Cancer Institute of Canada, 2004)
  • Lung cancer is the leading cause of cancer death for men in Canada 2004 (Canadian Cancer Statistics, National Cancer Institute of Canada, 2004)
  • Lung cancer is the leading cause of cancer death for women in Canada 2004 (Canadian Cancer Statistics, National Cancer Institute of Canada, 2004)
  • Lung cancer ranked number 1 cancer killer of American women in the US (Cancer Facts and Figures, American Cancer Society, 2004)
  • 65,700 deaths from lung cancer in the US 2002 (Cancer Facts and Figures, American Cancer Society, 2004)
  • Death rate for lung cancer continues to increase in women over the past decade in the US 2002 (Cancer Facts and Figures, American Cancer Society, 2004)
  • Death rate for lung cancer continues to decrease in men over the past decade in the US 2002 (Cancer Facts and Figures, American Cancer Society, 2004)
  • More women die of lung cancer than breast cancer in the US 2002 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 6,874 deaths from tracheal, bronchial and lung cancer in Australia in 1988 (Australian Bureau of Statistics, 2002)
  • 4,821 male deaths from tracheal, bronchial and lung cancer in Australia in 1988 (Australian Bureau of Statistics, 2002)
  • 5.4% of all deaths from tracheal, bronchial and lung cancer in Australia in 1988 (Australian Bureau of Statistics, 2002)
  • Caused 2,053 female deaths from tracheal, bronchial and lung cancer in Australia in 1988 (Australian Bureau of Statistics, 2002)
  • Death statistics for Lung and Bronchial Cancer in various countries:
    • 53.2 men per 100,000 population in the US 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 27.2 women per 100,000 population in the US 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 36.2 men per 100,000 population in Australia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 14.0 women per 100,000 population in Australia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 41.8 men per 100,000 population in Austria 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 10.8 women per 100,000 population in Austria 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 25.5 men per 100,000 population in Azerbaijan 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 4.5 women per 100,000 population in Azerbaijan 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 43.7 men per 100,000 population in Bulgaria 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 7.1 women per 100,000 population in Bulgaria 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 50.4 men per 100,000 population in Canada 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 25.0 women per 100,000 population in Canada 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 20.3 men per 100,000 population in Chile 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 7.0 women per 100,000 population in Chile 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 33.2 men per 100,000 population in China 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 13.5 women per 100,000 population in China 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 17.0 men per 100,000 population in Colombia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 8.5 women per 100,000 population in Colombia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 70.3 men per 100,000 population in Croatia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 9.4 women per 100,000 population in Croatia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 42.8 men per 100,000 population in Cuba 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 15.6 women per 100,000 population in Cuba 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 65.3 men per 100,000 population in Czech Republic 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 11.15 women per 100,000 population in Czech Republic 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 50.0 men per 100,000 population in Denmark 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 26.7 women per 100,000 population in Denmark 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 64.5 men per 100,000 population in Estonia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 8.6 women per 100,000 population in Estonia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 41.2 men per 100,000 population in Finland 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 7.4 women per 100,000 population in Finland 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 48.5 men per 100,000 population in France 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 6.7 women per 100,000 population in France 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 46.2 men per 100,000 population in Germany 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 9.6 women per 100,000 population in Germany 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 50.0 men per 100,000 population in Greece 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 7.4 women per 100,000 population in Greece 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 86.2 men per 100,000 population in Hungary 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 20.0 women per 100,000 population in Hungary 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 38.3 men per 100,000 population in Ireland 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 17.3 women per 100,000 population in Ireland 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 27.5 men per 100,000 population in Israel 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 9.3 women per 100,000 population in Israel 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 33.1 men per 100,000 population in Japan 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 9.6 women per 100,000 population in Japan 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 59.5 men per 100,000 population in Kazakhstan 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 8.3 women per 100,000 population in Kazakhstan 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 40.7 men per 100,000 population in Kyrgyzstan 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 7.3 women per 100,000 population per 100,000 population in Kyrgyzstan 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 59.1 men per 100,000 population in Latvia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000196.7 American Cancer Society)
    • 6.3 women per 100,000 population in Latvia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 56.5 men per 100,000 population in Lithuania 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 5.58 women per 100,000 population in Lithuania 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 39.8 men per 100,000 population in Macedonia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 6.6 women per 100,000 population in Macedonia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 16.7 men per 100,000 population in Mauritius 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 4.2 women per 100,000 population in Mauritius 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 22.1 men per 100,000 population in Mexico 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 8.2 women per 100,000 population in Mexico 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 59.7 men per 100,000 population in the Netherlands 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 14.8 women per 100,000 population in the Netherlands 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 39.3 men per 100,000 population in New Zealand 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 18.7 women per 100,000 population in New Zealand 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 31.7 men per 100,000 population in Norway 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 12.8 women per 100,000 population in Norway 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 71.5 men per 100,000 population in Poland 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 11.3 women per 100,000 population in Poland 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 29.5 men per 100,000 population in Portugal 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 4.8 women per 100,000 population in Portugal 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 42.1 men per 100,000 population in Republic of Moldova 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 6.2 women per 100,000 population in Republic of Moldova 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 45.1 men per 100,000 population in Romania 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 7.3 women per 100,000 population in Romania 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 68.2 men per 100,000 population in the Russian Federation 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 6.8 women per 100,000 population in the Russian Federation 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 60.7 men per 100,000 population in Slovakia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 7.8 women per 100,000 population in Slovakia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 55.3 men per 100,000 population in Slovenia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 10.1 women per 100,000 population in Slovenia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 49.4 men per 100,000 population in Spain 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 4.2 women per 100,000 population in Spain 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 22.6 men per 100,000 population in Sweden 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 12.6 women per 100,000 population in Sweden 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 13.2 men per 100,000 population in Trinidad and Tobago 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 4.3 women per 100,000 population in Trinidad and Tobago 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 18.9 men per 100,000 population in Turkmenistan 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 4.6 women per 100,000 population in Turkmenistan 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 48.6 men per 100,000 population in the UK 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 21.1 women per 100,000 population in the UK 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 19.4 men per 100,000 population in Venezuela 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 9.2 women per 100,000 population in Venezuela 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
  • 24 women per 100,000 population die of tracheal, bronchial and lung cancer in Australia 2002 (Australia’s Health 2004, AIHW)
  • 53 men per 100,000 population die of tracheal, bronchial and lung cancer in Australia 2002 (Australia’s Health 2004, AIHW)
  • Lung cancer caused 2,317 female deaths in Australia 2000 (AIHW and AACR, AIHW National Mortality Database, Australia’s Health 2004, AIHW)
  • Lung cancer accounted for 15% of female cancer deaths in Australia 2000 (AIHW and AACR, AIHW National Mortality Database, Australia’s Health 2004, AIHW)
  • Lung cancer accounted for 22.5 female deaths per 100,000 population in Australia 2000 (AIHW and AACR, AIHW National Mortality Database, Australia’s Health 2004, AIHW)
  • Death statistics by state in Australia:
    • Lung cancer caused 58.5 male deaths per 100,000 population in New South Wales 2000-2002 (AIHW National Mortality Database, Australia’s Health 2004)
    • Lung cancer caused 58.7 male deaths per 100,000 population in Victoria 2000-2002 (AIHW National Mortality Database, Australia’s Health 2004)
    • Lung cancer caused 64.2 male deaths per 100,000 population in Queensland 2000-2002 (AIHW National Mortality Database, Australia’s Health 2004)
    • Lung cancer caused 65.1 male deaths per 100,000 population in Western Australia 2000-2002 (AIHW National Mortality Database, Australia’s Health 2004)
    • Lung cancer caused 59 male deaths per 100,000 population in South Australia 2000-2002 (AIHW National Mortality Database, Australia’s Health 2004)
    • Lung cancer caused 69.3 male deaths per 100,000 population in Tasmania 2000-2002 (AIHW National Mortality Database, Australia’s Health 2004)
    • Lung cancer caused 43.9 male deaths per 100,000 population in Australian Capital Territory 2000-2002 (AIHW National Mortality Database, Australia’s Health 2004)
    • Lung cancer caused 80.9 male deaths per 100,000 population in Northern Territory 2000-2002 (AIHW National Mortality Database, Australia’s Health 2004)
    • Lung cancer caused 24.9 female deaths per 100,000 population in New South Wales 2000-2002 (AIHW National Mortality Database, Australia’s Health 2004)
    • Lung cancer caused 26.2 female deaths per 100,000 population in Victoria 2000-2002 (AIHW National Mortality Database, Australia’s Health 2004)
    • Lung cancer caused 25.5 female deaths per 100,000 population in Queensland 2000-2002 (AIHW National Mortality Database, Australia’s Health 2004)
    • Lung cancer caused 26.4 female deaths per 100,000 population in Western Australia 2000-2002 (AIHW National Mortality Database, Australia’s Health 2004)
    • Lung cancer caused 23.7 female deaths per 100,000 population in South Australia 2000-2002 (AIHW National Mortality Database, Australia’s Health 2004)
    • Lung cancer caused 35 female deaths per 100,000 population in Tasmania 2000-2002 (AIHW National Mortality Database, Australia’s Health 2004)
    • Lung cancer caused 25.3 female deaths per 100,000 population in Australian Capital Territory 2000-2002 (AIHW National Mortality Database, Australia’s Health 2004)
    • Lung cancer caused 37.9 female deaths per 100,000 population in Northern Territory 2000-2002 (AIHW National Mortality Database, Australia’s Health 2004)
  • Lung cancer caused 4,594 deaths in men in Australia 2000 (AIHW and AACR, AIHW National Mortality Database, Australia’s Health 2004, AIHW)
  • Lung cancer accounted for 22.9% of male cancer deaths in Australia 2000 (AIHW and AACR, AIHW National Mortality Database, Australia’s Health 2004, AIHW)
  • 54.8 deaths from lung cancer per 100,000 population occurred in men in Australia 2000 (AIHW and AACR, AIHW National Mortality Database, Australia’s Health 2004, AIHW)

Deaths from Lung cancer: medical news summaries

The following medical news items are relevant to death from Lung cancer:

Lung cancer: Hospitalization Statistics

The following are statistics from various sources about hospitalizations and Lung cancer:

  • 0.62% (79,192) of hospital consultant episodes were for malignant neoplasm of bronchus and lung in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 83% of hospital consultant episodes for malignant neoplasm of bronchus and lung required hospital admission in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 60% of hospital consultant episodes for malignant neoplasm of bronchus and lung were for men in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 40% of hospital consultant episodes for malignant neoplasm of bronchus and lung were for women in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • more stats »

Deaths from Lung cancer discussion

Lung Cancer: NWHIC (Excerpt)

Lung cancer is the largest single cause of cancer deaths in the U.S. (28% of all cancer deaths.) For years, men were at higher risk for lung cancer because of their higher smoking rates. However, with the rising number of women who smoke, lung cancer surpassed breast cancer in 1987 as the leading cause of cancer deaths among women. (Source: excerpt from Lung Cancer: NWHIC)

Lung Cancer: NWHIC (Excerpt)

Lung cancer is now the leading cause of cancer deaths among women. Cigarette smoking is the main culprit and responsible for 80% of these cancer deaths. Lung cancer has always been and continues to be more common in men than women but the difference is declining. Unfortunately statistics show that smoking rates among women are expected to surpass those among men by the year 2000. (Source: excerpt from Lung Cancer: NWHIC)

Premium articles about Death:

This section lists our premium articles on topics related to death. These are original authored articles on topics of great interest:

 

By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.

Home | Symptoms | Diseases | Diagnosis | Videos | Tools | Forum | About Us | Terms of Use | Privacy Policy | Site Map | Advertise